top of page
Image by Ari He

Our Team

Management

dstover_edited.jpg

Dr. David Stover

Founder and CEO

Dr. Stover has over 25 years of experience in both small molecule and biologics drug discovery and development at Agensys/Astellas, Novartis, MDS Proteomics, Kinetix Pharmaceuticals, and Ciba-Geigy.

Dr. Stover is an accomplished drug developer having been directly involved in 15 INDs, 8 of which reached clinical Proof of Concept so far. He earned his Ph.D. in Biochemistry at the University of Washington and holds a B.S. in Zoology from Duke University.

Sherie.jpeg

Dr. Sherie Morrison

Senior Scientific Advisor

Distinguished UCLA Professor with over 30 patents for antibody engineering inventions. (Co-founder/President Qwixel Therapeutics)

Joe Rice IMG_0947 R2_FULL_edited_edited.jpg

Joseph Rice

EVP of Operations

Joseph (Joe) has executive leadership experience across a range of disciplines in financial services.  In a 30 year career at Wells Fargo, he served as Chief Credit Officer and Chief Operational Risk Officer, and led several high-profile regulatory initiatives.  He earned a B.S. in Civil Engineering at UCLA and an M.B.A. from UC Berkeley.

Board Members

dstover_edited.jpg

Dr. David Stover

Dr. Stover has over 25 years of experience in both small molecule and biologics drug discovery and development at Agensys/Astellas, Novartis, MDS Proteomics, Kinetix Pharmaceuticals, and Ciba-Geigy.

Dr. Stover is an accomplished drug developer having been directly involved in 15 INDs, 8 of which reached clinical Proof of Concept so far. He earned his Ph.D. in Biochemistry at the University of Washington and holds a B.S. in Zoology from Duke University.

donald-rice-1.png

Donald B. Rice, Ph.D.

Co-founder, president & CEO of Agensys, Inc,  cancer biotech, sold to Astellas Pharma; Chair of Board of Scios, Inc., cardio biotech, sold to Johnson & Johnson.

Retired director of Chevron, Wells Fargo, Amgen, and Vulcan Materials.

Former President & COO, Teledyne, Inc.; Secretary of the U. S. Air Force; President & CEO, The RAND Corporation.

PhD, Economics & MS, Industrial Management, Purdue University; BS Chem Engr, University of Notre Dame.

George%201_edited.jpg

George Ayoub

Extensive executive leadership experience. (Co-founder/CEO of One Lambda and Qwixel Therapeutics)

photo.jpg

Kenan Turnacioglu, Ph.D.

Chairperson at Paige, a machine learning pathology company.  Board member at Immunai, biotech company.  Co-founder PointState Capital LP, formerly served at Duquesne Capital Management LLC and Credit Suisse.

B.A. from Rutgers University, Ph.D. University of Pennsylvania.

©2019 Nammi Therapeutics, Inc.

bottom of page